In summary, elevation of endogenous EETs by overexpression of CYP2J2 and sEH inhibition, as well as EET analogs, showed protective effects against cardiac remodeling, which was mediated mainly by prohibiting inflammation, apoptosis, fibrosis, and cardiac hypertrophy and promoting angiogenesis. Here, CYP2J2 is linked to cardiac hypertrophy.